SNDX Stock Summary and Trading Ideas (Syndax Pharmaceuticals | NASDAQ:SNDX)

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

What symbol and exchange does Syndax Pharmaceuticals shares trade?

Syndax Pharmaceuticals trades on the NASDAQ stock market under the symbol SNDX.

What is Syndax Pharmaceuticals stock price doing today?

As of March 26, 2026, SNDX stock price climbed to $24.70 with 1,245,413 million shares trading.

What is Syndax Pharmaceuticals's Beta?

SNDX has a beta of 0.49, meaning it tends to be less sensitive to market movements. SNDX has a correlation of 0.02 to the broad based SPY ETF.

How much is Syndax Pharmaceuticals worth?

SNDX has a market cap of $2.15 billion. This is considered a Mid Cap stock.

How much money does Syndax Pharmaceuticals make?

Last quarter Syndax Pharmaceuticals reported $69 million in Revenue and -$.78 earnings per share. This beat revenue expectation by $5 million and missed earnings estimates by -$.18.

What is the highest and lowest price Syndax Pharmaceuticals traded in the last 3 year period?

In the last 3 years, SNDX traded as high as $25.59 and as low as $8.58.

What are the top ETFs holding Syndax Pharmaceuticals?

The top ETF exchange traded funds that SNDX belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

Is Syndax Pharmaceuticals (SNDX) a good investment?

SNDX has outperformed the market in the last year with a price return of +88.1% while the SPY ETF gained +14.8%. SNDX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +16.0% and +3.0%, respectively, while the SPY returned -6.3% and -2.9%, respectively.

What are the support and resistance levels for Syndax Pharmaceuticals (SNDX)?

SNDX support price is $23.39 and resistance is $25.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNDX shares will trade within this expected range on the day.